Financial Reports
Related Searches:
Filter by:
May 28, 2008
Pall Corp.
3Q Revenues: $661.7 million (+18%)
YTD Revenues: $1.8 billion (+15%)
Comments: In the quarter, life science sales were $253.0 million (+3%) with Medical sales of $124.6 million (-3%) and BioPharmaceuticals sales of $12…
Read More »
May 13, 2008
Catalent Pharma Solutions
3Q Revenues: $453.3 million (+4%)
3Q Loss: $31 million (earnings were $21.8 million in 1Q07)
YTD Revenues: $1.4 billion (+8%)
YTD Loss: $72.5 million (earnings were $41.4 million YTD07)
Comments: The company a…
Read More »
May 12, 2008
Takeda FY Results (April 1, 2007 – March 31, 2008)
FY Revenues: $13.9 billion (+5%)
FY Earnings: $3.6 billion (+6%)
Comments: FY growth was driven by Actos sales of $4.0 billion (+18%) and Candesartan/Blopress sales of $2.2 billi…
Read More »
May 9, 2008
Draxis Health
1Q Revenues: $19.2 million (-9%)
1Q Loss: $2.4 million (earnings were $2.5 million in 1Q07)
Comments: Contract manufacturing revenues were $12.6 million (-11%) due to lower revenues of Genzyme's Hectorol. Sterile products…
Read More »
May 9, 2008
Eurand
1Q Revenues: $24.9 million (+24%)
1Q Loss: $1.6 million (loss of $1.2 million in 1Q07)
Comments: Product sales were $32.0 million (+17%). Royalties were $2.7 million (+103%). R&D expenses were $7.1 million (+21%). Revenues includ…
Read More »
May 7, 2008
Hospira
1Q Revenues: $888.7 million (+14%)
1Q Earnings: $65.4 million (loss of $29.4 million 1Q07)
Comments: In the Americas, pharmaceuticals revenues grew was 11% to $462.6 million. However, the "Other Pharmaceuticals" unit, which…
Read More »
May 7, 2008
Kendle
1Q Revenues: $158.8 million (+20%)
1Q Earnings: $5.6 million (+33%)
Comments: The company achieved record service revenues of $114.1
million and record new business awards of $180 million, both up 20%.
Total business a…
Read More »
May 5, 2008
AMRI
1Q Revenues: $53.6 million (+11%)
1Q Earnings: $4.7 million (+47%)
Comments: Total contract revenue increased to $45.3 million in the quarter (+10%). Discovery Services revenue was $13.3 million (+34%). Development and Small Scale…
Read More »
April 29, 2008
Covance
1Q Revenues: $434.0 million (+15%)
1Q Earnings: $49.1 million (+26%)
Comments: Early development revenues were $202.0 million (+13%) led by growth of toxicology and chemistry services. Operating income increased 16% to $50.6 million.…
Read More »
April 25, 2008
Amgen
1Q Revenues: $3.6 billion (-2%)
1Q Earnings: $1.1 billion (+2%)
Comments: Worldwide sales of Aranesp decreased 25% to $761 million, with U.S. sales down 38% to $405 million due to prescribing restrictions as a result of adverse cardiov…
Read More »
April 24, 2008
Bristol-Myers Squibb
1Q Revenues: $5.2 billion (+20%)
1Q Earnings: $661 million (-4%)
Comments: Growth was driven by pharmaceutical sales, which totaled $4.2 billion. U.S. sales increased 26% to $2.5 billion and International sales increased…
Read More »
April 24, 2008
ImClone Systems
1Q Revenues: $162.6 million (+15%)
1Q Loss: $55.9 million (earnings were $28.8 million in 1Q08)
Comments: Erbitux sales were $417.3 million (+12%). Royalty revenue related to Erbitux was $95.0 million (+24%). License f…
Read More »
April 23, 2008
Schering-Plough
1Q Revenues: $4.7 billion (+56%)
1Q Earnings: $291 million (-48%; earnings were $565 million in 1Q07)
Comments: Global Pharmaceutical sales totaled $3.6 billion, which includes $1.3 billion of Organon Biosciences revenues. S…
Read More »
April 23, 2008
Biogen Idec
1Q Revenues: $942 million (+32%)
1Q Earnings: $163 million (+23%)
Comments: Growth in the quarter was driven by Avonex sales (+19% to $536 million), Tysabri sales (+283% to $115 million) and Rituxan revenues from the joi…
Read More »
April 22, 2008
Wyeth
1Q Revenues: $5.7 billion (+6%)
1Q Earnings: $1.2 billion (-5%)
Comments: Pharmaceutical sales were $4.8 billion (+6%). Growth in the quarter was driven products, Enbrel, Prevnar and Nutritionals, offset, in part, by lower sales of th…
Read More »
